Department of Public Health Programmes, Randers Regional Hospital, Skovlyvej 15, 8930, Randers NØ, Denmark.
Department of Clinical Medicine, Aarhus University, Palle Juul-Jensen Boulevard 82, 8200, Aarhus N, Denmark.
Sci Rep. 2020 Sep 22;10(1):15427. doi: 10.1038/s41598-020-72279-x.
Our aim was to investigate whether receiving a false positive (FP) cervical cytology result affected subsequent cervical cancer screening participation. This Danish nationwide register-based cohort study included 502,380 women aged 22.5-45 attending cervical cancer screening in 2012-2014 with a normal (n = 501,003) or FP (n = 1,377) cytology screening result. A FP result was defined as a cervical cytology showing high grade cytological abnormalities followed by a normal or 'Cervical Intraepithelial Neoplasia grade 1' biopsy result. Women were categorized as subsequent participants if they had a cervical cytology within 24-42 months after their last screening or surveillance test. We compared subsequent participation among women with a normal versus a FP result, using odds ratios including 95% confidence intervals. Participation was slightly higher among women with FP results than among women with normal results (71.5% vs. 69.2%, p = 0.058). After adjustment for age and screening history, women with FP results participated significantly more than women with normal results (OR: 1.19, 95% CI 1.06-1.35). Women receiving a FP result did not participate less in subsequent cervical cancer screening than women receiving a normal result. In fact, the use of opportunistic screening seemed to be increased among women receiving a FP result.
我们的目的是调查收到假阳性(FP)宫颈细胞学结果是否会影响随后的宫颈癌筛查参与率。这项丹麦全国基于登记的队列研究纳入了 502380 名年龄在 22.5-45 岁之间于 2012-2014 年接受宫颈癌筛查的女性,她们的宫颈细胞学筛查结果正常(n=501003)或为 FP(n=1377)。FP 结果定义为宫颈细胞学显示高级别细胞学异常,随后为正常或“宫颈上皮内瘤变 1 级”活检结果。如果女性在最后一次筛查或监测测试后 24-42 个月内进行了宫颈细胞学检查,则将其归类为后续参与者。我们使用包括 95%置信区间的比值比比较了正常结果与 FP 结果女性的后续参与率。FP 结果女性的后续参与率略高于正常结果女性(71.5%对 69.2%,p=0.058)。在调整年龄和筛查史后,FP 结果女性的参与率显著高于正常结果女性(OR:1.19,95%CI 1.06-1.35)。与正常结果女性相比,收到 FP 结果的女性在随后的宫颈癌筛查中参与率并没有降低。事实上,FP 结果女性的机会性筛查似乎有所增加。